Healio Minute

In this edition, cancer and COVID-19 increase risk for thromboembolism, glofitamab shows curative potential in lymphoma, efgartigimod improves platelet counts, and more. Read the full coverage here: Biomarkers predict thromboembolism risk, mortality among people with cancer, COVID-19 Glofitamab shows 'curative potential' in relapsed/refractory diffuse large B-cell lymphoma Efgartigimod confers rap...

In this edition, alcohol consumption increases cancer risk, medical marijuana associated with lower rates of opioid prescriptions, lifelong stress increases risk for cancer mortality, and more. Read the full coverage here: Many Americans unaware of alcohol links to cancer risk Medical marijuana 'may be substituting for opioids for cancer-related pain' Lifelong stress may increase risk for cancer m...

In this episode, FDA grants fast track designation to REM-001; practice-changing treatment advances continue; proton partial breast radiotherapy appears effective and more. Read the full coverage here: FDA grants fast track designation to REM-001 for cutaneous metastatic breast cancer Practice-changing treatment advances continue in early-stage triple-negative breast cancer Proton partial breast r...

In this edition, fludarabine has been placed on the FDA's drug shortage list; epcoritamab is approved for advanced lymphoma; pembrolizumab with chemotherapy improves OS in gastric cancer, and more. Read the full coverage here: Fludarabine shortage requires flexibility, alternative approaches for CAR-T and HSCT FDA grants priority review to epcoritamab for advanced lymphoma Pembrolizumab regimen ex...

In this edition, foslevodopa-foscarbidopa improves motor symptoms in advanced PD, posterior surgery for treating cervical radiculopathy, Tysabri favored over IV in patients with relapsing-remitting MS and more. Read the full coverage here: Continuous subcutaneous foslevodopa-foscarbidopa improves motor symptoms in advanced PD Posterior surgery noninferior to anterior for treating cervical radiculo...

In this edition, risk factors linked to PD, digital brain health platform offers dementia risk assessment, Klotho protein levels linked to Alzheimer's and more. Read the full coverage here: Tremor, restless legs syndrome, schizophrenia among risk factors linked to PD Digital brain health platform offers rapid, accurate assessment of dementia risk Klotho protein levels linked to Alzheimer's, cognit...

In this edition, disparities among women in the surgical workforce, GSK withdraws belantamab mafodotin from US market, risk for lymphoma low after postmastectomy reconstruction, and more. Read the full coverage here: More women surgeon scientists receive NIH funding than in 2010, yet gender gaps remain GSK to withdraw multiple myeloma therapy from US market Risk for lymphoma after postmastectomy b...

In this edition, lung cancer screening critically low across the U.S, first in-human CRISPR test with gene replacement, racial and economic segregation linked to higher cancer mortality rates, and more. Read the full coverage here: Lung cancer screening rates in US 'simply unacceptable' First CRISPR-based cell therapy to use gene replacement feasible, safe for solid tumors Racial, economic segrega...

In this edition, best practice statements for celiac disease; older patients with IBD at risk for treatment failure with vedolizumab; Follow-up surveillance for post-colonoscopy CRC and more. Read the full coverage here: AGA releases 10 best practice statements for management of refractory celiac disease Older patients with IBD at higher risk for treatment failure with vedolizumab Follow-up survei...

In this edition, the importance of vaccination after cell therapy, artificial intelligence may help predict cardiotoxicity, experimental breast cancer vaccine generates immune response, and more. Read the full coverage here: Revaccination guidance after cell therapy established for some, 'evolving' for others Artificial intelligence may help predict cardiotoxicity in renal cell carcinoma Experimen...

In this edition, neurologic effects of COVID-19 among pediatric populations, FDA accepts NDA for extended-release carbidopa/levodopa, antihistamines could be promising therapy for Parkinson's disease and more. Read the full coverage here: Neurologic effects of COVID-19 persisted among pediatric populations in 2021 FDA accepts NDA for extended-release carbidopa/levodopa Parkinson's treatment Antihi...

In this episode, data show 'critical need' for universal genetic testing; patients with inflammatory breast cancer at high risk for brain metastases; palbociclib fails to benefit breast cancer subgroup and more. Read the full coverage here: Data show 'critical need' for universal genetic testing of patients with breast cancer Patients with inflammatory breast cancer at high risk for brain metastas...

In this edition, FDA approves Tecvayli for multiple myeloma, radiation and hormone therapy slows progression of prostate cancer, and more. Read the full coverage here: FDA approves Tecvayli for advanced multiple myeloma Adding radiation to hormone therapy slows progression of oligometastatic prostate cancer Use of cannabis during cancer treatment may have 'under-appreciated' financial impact Older...

In this edition, we bring you more news and Healio-exclusive interviews from the American Neurological Association Annual Meeting. Read the full coverage here: Diversity key to understanding genetics of neurodegenerative disease Assessing chemical exposures key to understanding neuro diseases and disorders VIDEO: Neurological complications can spur from certain infectious diseases Age, specific pa...

In this edition, Achalasia is associated with higher esophageal cancer risk; FDA rejects bulevirtide for hepatitis D and liver disease; real-world data on colonoscopy prep and more. Read the full coverage here: Achalasia associated with five-fold higher risk for esophageal cancer FDA rejects Gilead's bulevirtide for hepatitis D, compensated liver disease Polyethylene glycol, ascorbic acid cleanse...

In this edition, we bring you news and Healio-exclusive interviews from the American Neurological Association Annual Meeting. Read the full coverage here: Optimism in older adults improves functional recovery after stroke Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis VIDEO: Functional movement disorders diagnosed on presence of positive criteria Pain, sleep, mo...

In this edition, COVID-19 patients at risk for post-infection complications; VR for patients with back pain; FDA requests further analysis of Supernus Parkinson's treatment and more. Read the full coverage here: Evaluate headache characteristics to classify as migraine FDA grants breakthrough device designation for brain implant technology New genetic engineering company aims to develop neuroactiv...

In this edition, AGA speaks out on controversial NordICC data; first US patient enrolled in phase 3 trial of obefazimod; 'unprecedented' shift in hepatitis A outbreaks and more. Read the full coverage here: AGA speaks out on controversial NordICC data citing modest colonoscopy benefit for CRC First US patient enrolled in Abivax's phase 3 trial of obefazimod for ulcerative colitis Shift in hepatiti...

In this edition, COVID-19 patients at risk for post-infection complications; VR for patients with back pain; FDA requests further analysis of Supernus Parkinson's treatment and more. Read the full coverage here: COVID-19 patients at risk for neurological complications 1 year post-infection Patients with back pain benefited from at-home VR program FDA requests further analysis of Supernus Parkinson...

In this edition, preventive therapies should be offered for migraines; targeting neuropathic symptoms for poststroke pain; PDE5 inhibitors not associated with lower AD, dementia risk and more. Read the full coverage here: Range of preventive therapies should be offered for migraines Poststroke pain may be controlled by targeting neuropathic symptoms Treatment with PDE5 inhibitors not associated wi...

In this edition, endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding; Infliximab retreatment results in remission in patients with Crohn's disease; men who have sex with men twice as likely to be diagnosed with IBD and more. Read the full coverage here: Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding Infliximab retreatment results in remissio...

In this episode, FDA approves Rolvedon to reduce infection incidence; women want more education on sexual health during treatment; abemaciclib regimen shows further signs of benefit and more. Read the full coverage here: FDA approves Rolvedon to reduce infection incidence when taking certain anticancer drugs Women with breast cancer want more education on sexual health during treatment Abemaciclib...

In this edition, lecanemab study shows reduction in clinical decline for early AD; multimorbidity associated with increased risk for dementia, Crenezumab not effective in treating Alzheimer's disease and more. Read the full coverage here: Phase 3 study of lecanemab shows reduction in clinical decline in patients with early AD Multimorbidity associated with increased risk for dementia Crenezumab no...

In this edition, splash pads reduce child drowning risk but boost diarrhea outbreaks; FDA approves Konvomep for benign gastric ulcers; Xifaxan generic may be stalled until 2029 and more. Read the full coverage here: 'The water is recycled': Splash pads reduce child drowning risk, boost diarrhea outbreaks FDA approves Konvomep for benign gastric ulcers, risk reduction for upper GI bleeding Xifaxan...

In this edition, FDA votes to support approval of ALS therapy; partnership offers military veterans access to psychedelics; epidural steroid injections as alternate pain management options and more. Read the full coverage here: FDA advisory committee votes to support approval of ALS therapy Partnership offers military veterans access to psychedelics at home, abroad Epidural steroid injection an al...